Crossmark

The PSD-95 inhibitor NA-1 is delivered to the brain upon nasal administration with uptake into the olfactory bulb improved by co-administration with the cell-penetrating peptides lowPro and Tat

Crossref DOI link: https://doi.org/10.1007/s13346-025-01842-8

Published Online: 2025-04-03

Published Print: 2026-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schmidt, Solveig Elle

Joensen, Gunhild

Sandbjerg, Camilla

Thaysen, Maria

Gammelgaard, Bente https://orcid.org/0000-0002-9149-1014
Schindowski, Katharina https://orcid.org/0000-0003-2514-1654
Kristensen, Mie https://orcid.org/0000-0002-4086-5266
Funding

Funding for this research was provided by:

Copenhagen University
License Information

Text and Data Mining valid from 2025-04-03

Version of Record valid from 2025-04-03
More Information

Article History

Accepted: 19 March 2025

First Online: 3 April 2025

Declarations

Ethical approval: Animal studies were conducted in strict compliance with the Danish National Council for Animal Welfare under license no. 2021-15-0201-01030.

Competing interests: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below